Financials
- Financial year
- 2025
- Total assets
- €22,045
- Profit
- €12,342
- Solvency
- 56.0%
ZYNTRA ADVISORY
ActiveSummary
ZYNTRA ADVISORY has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,342 and a net result of €12,342. Its solvency ranks better than 46% of 612 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€22,045total assets 2025
- Equity
- €12,342
- Profit
- €12,342
Turnover not published (micro format)
Structure
- YARHZOU Sarah, Sahar, CyndiDirector
Accounts filed 27 days late
Why 93raises riskSize: total assets €22,045Founded in 2025lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 2.27, cash €22,045Show the evidence
Checked score
Score 2025
93
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 68% of its sector peers (NACE 72, micro)
Financial strength
Strong
Solvency
81
equity 56.0% of total assets
Liquidity
79
short-term debt 44.0% · cash 100.0%
Profitability
100
return on assets 56.0%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.27, above the usual 1.5; short-term debt: 44% and cash: 100% of total assets), and 44% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 50% on solvency, 65% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
27 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: YARHZOU Sarah, Sahar, Cyndi…
Key points
By topic
Board & ownership
- Board
- 1 member
- YARHZOU Sarah, Sahar, CyndiDirector
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Research and development on biotechnologyNACE 72101
- Founded
- 12-09-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 66
- Annual meeting
- Third Tuesday of June at 18:00
- Purpose
- “L'activité de conseil et d'assistance en matière financière, technique, informatique…” (deed in French)
- Statutory auditor
- No statutory auditor
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.